These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
518 related articles for article (PubMed ID: 31087508)
21. Identification of Novel Genes and Associated Drugs in Cervical Cancer by Bioinformatics Methods. Wang D; Liu Y; Cheng S; Liu G Med Sci Monit; 2022 Apr; 28():e934799. PubMed ID: 35428744 [TBL] [Abstract][Full Text] [Related]
22. Bioinformatics-based identification of key genes and pathways associated with colorectal cancer diagnosis, treatment, and prognosis. Wang C; Zhang L Medicine (Baltimore); 2022 Sep; 101(37):e30619. PubMed ID: 36123948 [TBL] [Abstract][Full Text] [Related]
23. Identification of potential hub genes via bioinformatics analysis combined with experimental verification in colorectal cancer. Zhou H; Yang Z; Yue J; Chen Y; Chen T; Mu T; Liu H; Bi X Mol Carcinog; 2020 Apr; 59(4):425-438. PubMed ID: 32064687 [TBL] [Abstract][Full Text] [Related]
24. Identification and clinicopathological analysis of potential p73-regulated biomarkers in colorectal cancer via integrative bioinformatics. Bareja C; Dwivedi K; Uboveja A; Mathur A; Kumar N; Saluja D Sci Rep; 2024 Apr; 14(1):9894. PubMed ID: 38688978 [TBL] [Abstract][Full Text] [Related]
25. Yang Q; Qi M; Chen Y; Tian S; Liao F; Dong W DNA Cell Biol; 2021 Jul; 40(7):921-935. PubMed ID: 34042518 [TBL] [Abstract][Full Text] [Related]
26. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis. Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502 [TBL] [Abstract][Full Text] [Related]
27. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis. Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116 [TBL] [Abstract][Full Text] [Related]
28. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer. Ebadfardzadeh J; Kazemi M; Aghazadeh A; Rezaei M; Shirvaliloo M; Sheervalilou R Med Oncol; 2021 Aug; 38(9):114. PubMed ID: 34390411 [TBL] [Abstract][Full Text] [Related]
29. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis. Wang Y; Zhou Z; Chen L; Li Y; Zhou Z; Chu X Mol Cell Biochem; 2021 Feb; 476(2):931-939. PubMed ID: 33130972 [TBL] [Abstract][Full Text] [Related]
30. Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for Colorectal Cancer. Liu X; Bing Z; Wu J; Zhang J; Zhou W; Ni M; Meng Z; Liu S; Tian J; Zhang X; Li Y; Jia S; Guo S Med Sci Monit; 2020 Jan; 26():e918906. PubMed ID: 31893510 [TBL] [Abstract][Full Text] [Related]
31. Identification of potential core genes in esophageal carcinoma using bioinformatics analysis. Yang X; Tian M; Zhang W; Chai T; Shen Z; Kang M; Lin J Medicine (Baltimore); 2021 Jul; 100(27):e26428. PubMed ID: 34232175 [TBL] [Abstract][Full Text] [Related]
32. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer. Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036 [TBL] [Abstract][Full Text] [Related]
33. Identification of hub genes in colorectal cancer based on weighted gene co-expression network analysis and clinical data from The Cancer Genome Atlas. Zhang Y; Luo J; Liu Z; Liu X; Ma Y; Zhang B; Chen Y; Li X; Feng Z; Yang N; Feng D; Wang L; Song X Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34308980 [TBL] [Abstract][Full Text] [Related]
34. Identification of intestinal flora-related key genes and therapeutic drugs in colorectal cancer. Zhang J; Zhang H; Li F; Song Z; Li Y; Zhao T BMC Med Genomics; 2020 Nov; 13(1):172. PubMed ID: 33198757 [TBL] [Abstract][Full Text] [Related]
35. Investigation of Potential Mechanisms Associated with Non-small Cell Lung Cancer. Shi Y; Zhu S; Yang J; Shao M; Ding W; Jiang W; Sun X; Yao N J Comput Biol; 2020 Sep; 27(9):1433-1442. PubMed ID: 32048869 [TBL] [Abstract][Full Text] [Related]
36. The promising novel biomarkers and candidate small molecule drugs in lower-grade glioma: Evidence from bioinformatics analysis of high-throughput data. Zhang B; Wu Q; Xu R; Hu X; Sun Y; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Wang Z; Zhou YL J Cell Biochem; 2019 Sep; 120(9):15106-15118. PubMed ID: 31020692 [TBL] [Abstract][Full Text] [Related]
37. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments. Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343 [TBL] [Abstract][Full Text] [Related]
38. Bioinformatics Analysis of Prognosis-Related Genes and Expression of CXCL8 in Colorectal Cancer. Yao Z; Pan X; Chen W; Pei Y; Chen C; Huang Y; Liu S; Liu Y Biomed Res Int; 2022; 2022():3149887. PubMed ID: 35845924 [TBL] [Abstract][Full Text] [Related]
39. Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for Cervical Cancer: A Bioinformatics Analysis. Qiu HZ; Huang J; Xiang CC; Li R; Zuo ED; Zhang Y; Shan L; Cheng X Technol Cancer Res Treat; 2020; 19():1533033820980112. PubMed ID: 33302814 [TBL] [Abstract][Full Text] [Related]
40. Identification of Key Genes in Colorectal Cancer Regulated by miR-34a. Wang T; Xu H; Liu X; Chen S; Zhou Y; Zhang X Med Sci Monit; 2017 Dec; 23():5735-5743. PubMed ID: 29197895 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]